Start Date: 5/6/2017 7:45 AM EDT
End Date: 5/7/2017 3:00 PM EDT
Venue Name: NYU Langone Medical Center Location:
Smilow Seminar Room/Smilow MPR
550 First Avenue
New York, NY United States 10016
Register Via Fax*
*After 12 pm on May 4, 2017, only onsite registration is available, provided the course has not reached capacity. Onsite registrants will incur an additional $20 fee. Registration is non-transferable.
Mark V. Sherrid, MD
Daniel G. Swistel, MD
Full Fee: $350
NYU Langone/NYU Lutheran Attending Faculty*: $150
Reduced Fee**: $75
Current Cardiology Residents & Fellows: Waived
*Must provide a valid NYU Langone/NYU Lutheran ID
**Reduced fee applies to NYU School of Medicine alumni, former residents and fellows; physicians employed by the Department of Veterans Affairs Medical Center; full-time active military personnel; retired physicians; and all other non-physician healthcare professionals.
Physicians, physician trainees, nurses, nurse practicitioners, physician assistants and allied health professionals
Hypertrophic Cardiomyopathy (HCM) is one of the most challenging diseases encountered in cardiology practice because of the diversity of its expression and unpredictable clinical course. In this symposium the evolving treatments for HCM symptoms will be discussed: medical treatment including disopyramide for obstruction, new surgical approaches to the mitral valve as adjuncts to myectomy, revised pathophysiologic understanding of SAM and other modalities such as alcohol septal ablation and AFib ablation. Implantable devices to prevent sudden death will be discussed in detail, focusing on risk stratification.
Current echocardiographic diagnosis and HCM subtypes will be covered, as well as stress echo-cardiography to provoke latent LVOT obstruction. Also, state of the art MRI in HCM will be covered, as well as genotype analysis for family screening. Pre-athletic participation screening will be covered. Installation of an automatic external defibrillator at every athletic playing field and practice session will be discussed. We will discuss investigational initiatives such as new pharmacologic therapy for mitigation of symptoms and slowing the development of phenotype as well as investigational interventional approaches to the mitral valve for treatment of obstruction in those with contraindications to myectomy.
At the conclusion of this activity, participants should be able to:
- Accurately interpret echocardiography findings for the appropriate diagnosis of HCM
- Recognize risk factors for sudden cardiac death in HCM patients
- Recognize in what circumstances disopyramide should be started and manage initiation and maintenance of drug
- Apply surgical recommendations and manage comorbidities adequately
- Propose individually tailored recommendation regarding invasive therapy for obstructive HCM and adequately explain and translate risks and benefits of each option
- Appropriately perform screening for family members of those with HCM. Understand utility of genotype analysis and how to counsel families about it
- perform thorough pre-athletic screening history and physical. They should be able to discuss and describe current AED requirements
The NYU Post-Graduate Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The NYU Post-Graduate medical School designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
in order to request a refund, you must email firstname.lastname@example.org no later than 14 days prior to the first day of the course. An administrative fee of $75 will be deducted from your refund. Cancellations of no-shows after this date are not eligible for a refund.
Course Cancellation Policy
If a course is cancelled due to inclement weather, insufficient enrollment or any other reason, NYU PGMS will refund registration fees in full. NYU PGMS will provide at least two weeks advance notice if cancelling due to insufficient enrollment and as soon as possible in all other circumstances. NYUPGMS is not responsible for any airfare, hotel or other non-cancellable costs incurred by the registrant.